DREAM genetic switch: link between lifespan and diseases https://ymaho.com/dream-genetic-switch-link-between-lifespan-and-diseases
Low DREAM activity increases lifespan in 92 species and protects against Alzheimer's disease. Learn about the genetic switch of aging and its impact on the risk of age-related diseases. Read details.
Smart drugs for cancer and HIV: development by Siberian scientists https://ymaho.com/smart-drugs-for-cancer-and-hiv-development-by-siberian-scientists
Institute of the Siberian Branch of the Russian Academy of Sciences creates therapeutic oligonucleotides — molecules that switch off cancer and HIV genes. The development of phosphorylguanidines promises treatment without side effects. Learn how Russian genetic engineering bypasses Western patents.
Personalized CRISPR therapy saved an infant: in vivo breakthrough https://ymaho.com/personalized-crispr-therapy-saved-an-infant-in-vivo-breakthrough
A child with the ultra-rare CPS1 mutation survived thanks to personalized CRISPR therapy in 6 months. Learn about the breakthrough in genetic engineering and N-of-1 platforms.
MIT synthetic circuit reverses cellular aging https://ymaho.com/mit-synthetic-circuit-reverses-cellular-aging
MIT scientists reprogrammed cell aging without cancer risk. Learn how the genetic switch works and when to expect therapy. Read more.
Stem Cells: GMP Standardization and Clinical Prospects https://ymaho.com/stem-cells-gmp-standardization-and-clinical-prospects
Stem Cell Market Overview: Why Without GMP Standardization Therapy Will Not Become Widespread. Safety Issues, Genetic Modification, and FDA Regulatory Trends 2026. Find Out Who Will Benefit from the New Rules.
RNA editing with light: CRISPR/Cas13d for deep tissues https://ymaho.com/rna-editing-with-light-crispr-cas13d-for-deep-tissues
Scientists created a photoactivatable system paCas13d with nanoparticles. The technology cured bone necrosis in mice without harming systemic therapy. Learn how IR light controls genes at tissue depth.
Gene therapy of aging in the Russian Federation: RAGE blockade and sarcopenia exosomes https://ymaho.com/gene-therapy-of-aging-in-the-russian-federation-rage-blockade-and-sarcopenia-exosomes
Russian scientists are creating the world's first anti-aging drugs: RAGE gene blocker and exosome rejuvenation. The Ministry of Education and Science promises clinical use by 2030. Learn how transplantation of 'young' vesicles restores muscles and why the budget exceeds 2 trillion rubles.
In vivo gene editing: phase 3 of HAE therapy successful https://ymaho.com/in-vivo-gene-editing-phase-3-of-hae-therapy-successful
First ever successful phase 3 in vivo gene editing: lonvo-z therapy reduces HAE attacks by 87%. Learn about the breakthrough and discontinuation of prophylaxis.
evoCAST: gene insertion without DNA cuts — breakthrough 2026 https://ymaho.com/evocast-gene-insertion-without-dna-cuts-breakthrough-2026
The new evoCAST tool inserts whole genes without double-strand breaks. Efficiency increased 400-fold. Learn how this will change gene therapy.
CRISPR in vivo reduces cholesterol by 60% in VERVE-102 study https://ymaho.com/crispr-in-vivo-reduces-cholesterol-by-60-in-verve-102-study
Single infusion of VERVE-201 sustainably lowers LDL by more than 60%. Learn how CRISPR editing is changing the hypercholesterolemia therapy market. Read the analysis.